Ladies and gents, The specialist of microneedling has spoken. Who cares about Follica released on the market, since the protocol can be replicated with current OTC products? And why caring about Replicel with results inferior to minoxidil?Fcking joke company like Follica, I doubt their treatments will be on the market by 2030 at this rate.
Lol why do you feel the need to reply to each of my comments with such bitterness? Focus on your chinese cope chemicals you put on your head.Ladies and gents, The specialist of microneedling has spoken. Who cares about Follica released on the market, since the protocol can be replicated with current OTC products? And why caring about Replicel with results inferior to minoxidil?
I don't get it. What happens now ?
I like your optimism boy.it is a nice situation forced By RepliCel.
Shiseido is doing clinical trials to find the Most effective dosis For the Cell based treatment since the Last year. Now they should know whether it is Worth to commercialize RCH-01 or not.
now Replicel set Shiseido under pressure with their law strategy.
Shiseido has 2 options:
- Option Nr. 1: Fight For the hairloss product. (Share their data with Replicel to fullfill the contract. Or Buy the worldwide rights For commercilaizing RCH-01)
——> we would have the clearity that RCH-01 Works and will be commercilaized possibly in 2023
Option Nr. 2: Shiseido gives a f*** on this arbitration and give up the clinical trials bow
Because the product isnt effective enough
—> we would have the clearity that RCH-01 Doesnt work and would neither be commercilized By Shiseido nor By replicel.
we will finally know about Shiseidos strategy in a couple of weeks because RepliCel Did this Action Right now. They Seem very confident about their legal action But After all the Most important is that Shiseido will confirm that the RCH-01 is going to happen. It is now all or nothing
I like your optimism boy.
The licence agreement has just been terminated. I don't know what more you need to understand this RCH-01 treatment is a joke.
Sorry to be pessimistic about this but:If this RCH-01 treatment is a joke Why Shiseido is doing a dose finding study now and is rigoros fighting For Holding their License against a Little penny Stock Company like Replicel? Why they make such Big efforts For a joke treatment ??
Sorry to be pessimistic about this but:
- First, listed companies must publicly disclose their litigations when they arise;
- Second, Shiseido's interest is to claim it will commit its best efforts (the latter being legally non-binding) to fight against any action intended against the listed company, to preven any stock price dip;
- Third, Shiseido's press release was issued on October 19th. Replicel's announcement of license agreement termination with Shiseido was released one month later, which clearly means the arbitration case is moving in one direction.
Sorry if this may sound pedantic; it really ain't my intent. I work in finance and I have seen these litigations just too many times.
Date: 2020. (also lol did you save my posts?)